ICICI Prudential Life Insurance delivered a quarter that reinforced its evolving investment narrative: moderate near-term growth, but structurally improving profitability.

Infosys has entered 2026 with early but credible signs of a discretionary demand revival, prompting Motilal Oswal Financial Services to reiterate its BUY rating on the stock.

ICICI Lombard’s Q3FY26 performance reflects a quarter of optical weakness driven by accounting mechanics and one-off costs, rather than a deterioration in business fundamentals.

Ventura Securities has initiated coverage on Jubilant Pharmova Ltd with a "BUY" recommendation at the current market price of Rs 1,067, assigning a 24-month price target of Rs 1,557, representing a

Deven Choksey research has suggested BUY Call for technology major Infosys after robust quarterly numbers and a positive guidance.

Kotak Mahindra Bank’s 1:5 stock split has come into effect from January 14, 2026. Each equity share of face value Rs 5 has been subdivided into five shares of face value Rs 1.